LivaNova PLC Finite-Lived Intangible Assets, Accumulated Amortization
LivaNova PLC (LIVN) had Finite-Lived Intangible Assets, Accumulated Amortization of $196.91 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-02-25
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $196.91M.
- 2024-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $164.35M.
- 2023-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $155.57M.
- 2022-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $170.17M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2025-12-31 | $196.91M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $164.35M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $155.57M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $170.17M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $150.60M 10-K · filed 2023-02-27 | |
| 2020-12-31 | $131.46M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $148.04M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $108.27M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $74.91M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $37.05M 10-K · filed 2018-02-28 | $52.69M 10-K · filed 2017-03-01 |
| 2016-09-30 | $43.43M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $31.20M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $26.09M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $12.44M 10-K · filed 2017-03-01 | |
| 2015-10-18 | $4.37M 10-Q · filed 2015-12-08 | |
| 2015-04-24 | $4.06M 10-K · filed 2017-03-01 | $4.06M 10-Q · filed 2015-12-02 |
| 2014-04-25 | $3.46M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |